Effects of lamotrigine on cognition and behavior compared to carbamazepine as monotherapy for children with partial epilepsy

Brain and Development

Volumn 34, Issue 10, 2012, Pages 818-823

  Eun, So Hee ^a   Eun, Baik Lin ^a   Lee, Joon Soo ^b   Hwang, Yong Seung ^c   Kim, Ki Joong ^c   Lee, Young Mock ^b   Lee, In Goo ^d   Lee, Munhyang ^e   Ko, Tae Sung ^f   Kim, Jeong Tae ^g   Eom, Soyong ^b   Kim, Heung Dong ^b  

^a Korea University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

^d The Catholic University of Korea College of Medicine   (South Korea)

^e Sungkyunkwan University School of Medicine   (South Korea)

^f University of Ulsan College of Medicine   (South Korea)

^g Eulji University   (South Korea)

Author keywords

Behavior; Child; Cognition; Lamotrigine; Partial epilepsy

Indexed keywords

CARBAMAZEPINE; LAMOTRIGINE;

ARTICLE; BEHAVIOR; CHILD; CLINICAL ASSESSMENT TOOL; COGNITION; CONNER SCALE; CONTROLLED STUDY; DRUG DOSE TITRATION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; FEMALE; FOCAL EPILEPSY; HUMAN; INTELLIGENCE; KOREAN CHILD BEHAVIOR CHECKLIST; MAINTENANCE DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; NEUROPSYCHOLOGICAL TEST; OUTCOME ASSESSMENT; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; RASH; SCHOOL CHILD; SEIZURE; SOMNOLENCE; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ANTICONVULSANTS; BEHAVIOR; CARBAMAZEPINE; CHILD; COGNITION; EPILEPSIES, PARTIAL; FEMALE; HUMANS; MALE; TREATMENT OUTCOME; TRIAZINES;

EID: 84867720212     PISSN: 03877604     EISSN: 18727131     Source Type: Journal    
DOI: 10.1016/j.braindev.2012.03.006     Document Type: Article

References (18)

1. Smith D.B., Craft B.R., Collins J., Lattson R.H., Cramer J.A. Behavioral characteristics of epilepsy patients compared with normal controls. Epilepsia 1986, 27:760-768. The VA Cooperative Study Group 118.
2. Elger C.E., Helmstaedter C., Kurthen M. Chronic epilepsy and cognition. Lancet Neurol 2004, 3:663-672.
3. Stafstrom C.E. Assessing the behavioral and cognitive effects of seizures on the developing brain. Prog Brain Res 2002, 135:377-390.
4. Saetre E., Perucca E., Isojärvi J., Gjerstad L. An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly. Epilepsia 2007, 48:1292-1302. LAM 40089 Study Group.
5. Meador K.J., Loring D.W., Ray P.G., Murro A.M., King D.W., Perrine K.R., et al. Differential cognitive and behavioral effects of carbamazeine and lamotrigine. Neurology 2001, 56:1177-1182.
6. Brodie M.J., Overstall P.W., Giorgi L. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. Epilepsy Res 1999, 37:81-87.
7. Steiner T.J., Dellaportas C.I., Findley L.J., Gross M., Gibberd F.B., Perkin G.D., et al. Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin. Epilepsia 1999, 40:601-607.
8. Gillham R., Baker G., Thompson P., Birbeck K., McGuire A., Tomlinson L., et al. Standardisation of a self-report questionnaire for use in evaluating cognitive, affective and behavioural side-effects of anti-epileptic drug treatments. Epilepsy Res 1996, 24:47-55.
9. Smith D., Baker G., Davies G., Dewey M., Chadwick D.W. Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia 1993, 34:312-322.
10. Eun S.H., Kim H.D., Eun B.L., Lee I.K., Chung H.J., Kim J.S., et al. Comparative trial of low- and high-dose zonisamide as monotherapy for childhood epilepsy. Seizure 2011, 20:558-563.
11. Motamedi G., Meador K. Epilepsy and cognition. Epilepsy Behav 2003, 4:25-38.
12. Eriksson A.S., Knutsson E., Nergardh A. The effect of lamotrigine on epileptiform discharges in young patients with drug-resistant epilepsy. Epilepsia 2001, 42:230-236.
13. Uvebrant P., Bauziene R. Intractable epilepsy in children. The efficacy of lamotrigine treatment, including non-seizure-related benefits. Neuropediatrics 1994, 25:284-289.
14. Labiner D.M., Ettinger A.B., Fakhoury T.A., Chung S.S., Shneker B., Tatum Iv W.O., et al. Effects of lamotrigine compared with levetiracetam on anger, hostility, and total mood in patients with partial epilepsy. Epilepsia 2009, 50:434-442.
15. Gamble C.L., Williamson P.R., Marson A.G. Lamotrigine versus carbamazepine monotherapy for epilepsy. Cochrane Database Syst Rev 2006, 25:CD001031.
16. Nieto-Barrera M., Brozmanova M., Capovilla G., Christe W., Pedersen B., Kane K., et al. A comparison of monotherapy with lamotrigine or carbamazepine in patients with newly diagnosed partial epilepsy. Epilepsy Res 2001, 46:145-155.
17. Vermeulen J., Aldenkamp A.P. Cognitive side-effects of chronic antiepileptic drug treatment: a review of 25 years of research. Epilepsy Res 1995, 22:65-95.
18. Meador K.J., Loring D.E., Huh K., Calagher B.B., King D.W. Comparative cognitive effects of anticonvulsants. Neurology 1990, 40:391-394.